ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 March 2024
|
|
karzarski
|
32 |
13K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
32
|
13K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 March 2024
|
|
karzarski
|
32 |
13K |
3 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
32
|
13K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Notification of cessation of securities - PAB
|
|
karzarski
|
21 |
5.2K |
1 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
21
|
5.2K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 March 2023
|
|
karzarski
|
102 |
36K |
9 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
102
|
36K
|
9
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 March 2023
|
|
karzarski
|
102 |
36K |
1 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
102
|
36K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Updated guidance for PAT-DX1 phase 1 clinical study
|
|
karzarski
|
125 |
48K |
15 |
01/04/23 |
01/04/23 |
ASX - By Stock
|
125
|
48K
|
15
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
karzarski
|
348 |
131K |
6 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
348
|
131K
|
6
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2022
|
|
karzarski
|
37 |
13K |
4 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
37
|
13K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
4 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
140
|
63K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Change in substantial holding
|
|
karzarski
|
24 |
8.7K |
6 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
24
|
8.7K
|
6
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
karzarski
|
348 |
131K |
22 |
27/01/23 |
27/01/23 |
ASX - By Stock
|
348
|
131K
|
22
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
10 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
140
|
63K
|
10
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
3 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
140
|
63K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
5 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
140
|
63K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
karzarski
|
348 |
131K |
7 |
06/01/23 |
06/01/23 |
ASX - By Stock
|
348
|
131K
|
7
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
karzarski
|
348 |
131K |
11 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
348
|
131K
|
11
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
karzarski
|
348 |
131K |
3 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
348
|
131K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
5 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
140
|
63K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
4 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
140
|
63K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Looking forward to the next 12 months with great excitement.
|
|
karzarski
|
98 |
42K |
3 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
98
|
42K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
3 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
140
|
63K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT DX3 Crosses Blood Brain Barrier in Healthy Animals
|
|
karzarski
|
55 |
23K |
16 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
55
|
23K
|
16
|
|
ASX - By Stock
|
PAB |
Re:
Short term future of PAB
|
|
karzarski
|
83 |
38K |
16 |
09/10/22 |
09/10/22 |
ASX - By Stock
|
83
|
38K
|
16
|
|
ASX - By Stock
|
PAB |
Re:
Short term future of PAB
|
|
karzarski
|
83 |
38K |
4 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
83
|
38K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
1 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
140
|
63K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
6 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
140
|
63K
|
6
|
|
ASX - By Stock
|
PAB |
Re:
Short term future of PAB
|
|
karzarski
|
83 |
38K |
19 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
83
|
38K
|
19
|
|
ASX - By Stock
|
PAB |
Re:
Ann: CBCF funding to support deoxymab brain cancer development
|
|
karzarski
|
30 |
14K |
13 |
03/09/22 |
03/09/22 |
ASX - By Stock
|
30
|
14K
|
13
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
8 |
29/08/22 |
29/08/22 |
ASX - By Stock
|
140
|
63K
|
8
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 30 June 2022
|
|
karzarski
|
30 |
11K |
5 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
30
|
11K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
9 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
140
|
63K
|
9
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 Engineering Run Successfully Completed
|
|
karzarski
|
102 |
36K |
4 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
102
|
36K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 Engineering Run Successfully Completed
|
|
karzarski
|
102 |
36K |
8 |
16/07/22 |
16/07/22 |
ASX - By Stock
|
102
|
36K
|
8
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 Engineering Run Successfully Completed
|
|
karzarski
|
102 |
36K |
13 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
102
|
36K
|
13
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 Engineering Run Successfully Completed
|
|
karzarski
|
102 |
36K |
11 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
102
|
36K
|
11
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 Engineering Run Successfully Completed
|
|
karzarski
|
102 |
36K |
5 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
102
|
36K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 Engineering Run Successfully Completed
|
|
karzarski
|
102 |
36K |
11 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
102
|
36K
|
11
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 Engineering Run Successfully Completed
|
|
karzarski
|
102 |
36K |
15 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
102
|
36K
|
15
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 Engineering Run Successfully Completed
|
|
karzarski
|
102 |
36K |
11 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
102
|
36K
|
11
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
18 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
140
|
63K
|
18
|
|
ASX - By Stock
|
PAB |
Re:
Ann: New Mechanism By Which PAT-DX1 May Reduce Cancer Metastasis
|
|
karzarski
|
125 |
43K |
16 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
125
|
43K
|
16
|
|
ASX - By Stock
|
PAB |
Re:
Ann: New Mechanism By Which PAT-DX1 May Reduce Cancer Metastasis
|
|
karzarski
|
125 |
43K |
11 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
125
|
43K
|
11
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Patrys CEO to present at Bioshares Biotech Summit
|
|
karzarski
|
26 |
13K |
7 |
12/06/22 |
12/06/22 |
ASX - By Stock
|
26
|
13K
|
7
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
6 |
28/05/22 |
28/05/22 |
ASX - By Stock
|
140
|
63K
|
6
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
3 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
140
|
63K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Patrys CEO to present at Bioshares Biotech Summit
|
|
karzarski
|
26 |
13K |
4 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
26
|
13K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 March 2022
|
|
karzarski
|
23 |
11K |
5 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
23
|
11K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 March 2022
|
|
karzarski
|
23 |
11K |
10 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
23
|
11K
|
10
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
karzarski
|
140 |
63K |
2 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
140
|
63K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Stable Cell Line for Production of PAT-DX3 Established
|
|
karzarski
|
116 |
45K |
0 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
116
|
45K
|
0
|
|